The Beauty Health Company (NASDAQ:SKIN) Given Consensus Recommendation of “Reduce” by Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have been given a consensus recommendation of “Reduce” by the seven ratings firms that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $2.40.

A number of brokerages have recently weighed in on SKIN. Jefferies Financial Group reaffirmed a “hold” rating and set a $1.60 target price on shares of Beauty Health in a research note on Wednesday, January 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Beauty Health in a report on Friday, October 31st. TD Cowen upped their target price on Beauty Health from $1.50 to $1.65 and gave the stock a “hold” rating in a report on Wednesday, January 21st. Wall Street Zen lowered Beauty Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, Zacks Research lowered Beauty Health from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 21st.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of SKIN. Invesco Ltd. grew its stake in shares of Beauty Health by 6.6% in the second quarter. Invesco Ltd. now owns 98,427 shares of the company’s stock worth $188,000 after acquiring an additional 6,059 shares during the period. ProShare Advisors LLC boosted its holdings in Beauty Health by 45.5% in the second quarter. ProShare Advisors LLC now owns 23,447 shares of the company’s stock worth $45,000 after purchasing an additional 7,336 shares during the last quarter. Rhumbline Advisers grew its position in Beauty Health by 5.7% in the 3rd quarter. Rhumbline Advisers now owns 150,124 shares of the company’s stock worth $299,000 after purchasing an additional 8,142 shares during the period. The Manufacturers Life Insurance Company raised its stake in Beauty Health by 33.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 41,488 shares of the company’s stock valued at $79,000 after buying an additional 10,410 shares during the last quarter. Finally, Public Employees Retirement System of Ohio bought a new position in shares of Beauty Health during the 3rd quarter valued at $26,000. 93.26% of the stock is currently owned by institutional investors.

Beauty Health Price Performance

SKIN opened at $1.50 on Monday. The company has a debt-to-equity ratio of 5.53, a quick ratio of 4.07 and a current ratio of 4.98. The stock has a market capitalization of $191.25 million, a PE ratio of -6.82 and a beta of 1.16. The stock’s 50 day moving average price is $1.48 and its 200-day moving average price is $1.68. Beauty Health has a 52-week low of $0.78 and a 52-week high of $2.69.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings results on Thursday, November 6th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01). The business had revenue of $70.66 million during the quarter, compared to analysts’ expectations of $68.33 million. Beauty Health had a negative return on equity of 19.70% and a negative net margin of 3.87%. On average, equities research analysts predict that Beauty Health will post -0.25 EPS for the current year.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.